Case Study
Private Planes

On 27 July 2000, FUZE Biotech (now Fuze Technologies) applied the long-lasting antimicrobial FUZE surface treatment to private planes for a company based in Portsmouth, NH. On 7 August 2000, samples were collected from several corresponding locations in 2 treated planes (tail numbers 959 and 531) along with a control group of untreated planes (tail numbers 539 and 749). These samples were tested to provide a comparison of the microbial counts on FUZE-treated planes as compared to untreated planes.

The testing was performed by LexaMed, an independent third-party laboratory. The samples were incubated, and then the total number of colony forming units (CFUs) of both bacteria and fungus were counted. A CFU count includes only the viable (alive and capable of multiplying) organisms.

The table below shows the bacterial counts, fungal counts, and percentage reduction for each location.